Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Groome Capital was a Canadian financial services and brokerage firm focused on institutional financing, private placements, research, sales, and trading for emerging growth companies. The firm was based in Montreal and also had a Toronto presence, and it appears to have operated under entities including Groome Capital.Com Inc. and Groome Capital Advisory Inc. Although it had exposure to biotechnology financings as part of its broader capital-markets activity, it was not itself a life sciences or healthcare operating company. Its brokerage division was acquired by Desjardins Securities in 2001, and multiple business-directory sources now indicate that the original company is closed or inactive. The business is best characterized as an historical Canadian capital-markets firm rather than a biotech, pharma, or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Groome Capital.